JPML Won't Separate La. Avandia Suit From MDL

Law360, New York (May 23, 2011, 8:16 PM EDT) -- A federal judicial panel on Friday rejected Louisiana's bid to keep its suit alleging GlaxoSmithKline PLC failed to warn consumers of the risks associated with its diabetes medication Avandia separate from parallel multidistrict litigation in Pennsylvania.

The U.S. Judicial Panel on Multidistrict Litigation denied the state's motion to vacate the panel's earlier order conditionally transferring its action in Louisiana to the MDL over the drug's risks currently pending in Pennsylvania before Judge Cynthia M. Rufe.

Since Avandia was linked to heart disease in 2010, the drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.